Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Thyroid Lesions Examined by Scanning Acoustic Microscope

By LabMedica International staff writers
Posted on 05 Mar 2014
A scanning acoustic microscope (SAM) uses ultrasound to image an object by plotting the speed-of-sound (SOS) through tissues on screen, and because hard tissues result in great SOS, SAM can provide data on the tissue elasticity.

Scanning acoustic microscopy uses ultrasound at 120 MHz with almost the same resolution of approximately 12.5 μm as the low magnification of a light microscope (LM), and it had been found useful in generating useful information on the lung, stomach, and lymph node lesions.

Scientists at Hamamatsu University School of Medicine (Japan) selected and examined formalin-fixed, paraffin-embedded blocks that were flat-sectioned in 10 μm thick sections from patients with inflammatory non-neoplastic and neoplastic thyroid lesions. More...
Specimens were randomly selected from the computer database of pathological sections and typical lesions of thyroid diseases were identified based on hematoxylin and eosin sections.

The formalin-fixed, paraffin sections were scanned with a 120 MHz transducer using the SAM model AMS-50AI (Honda Electronics Co, Ltd; Toyohashi, Japan). SOS through each area was calculated and plotted on the screen to provide histological images, and SOS of each lesion was compared and statistically analyzed.

High-concentrated colloids, red blood cells, and collagen fibers showed pronounced SOS while low-concentrated colloids, parathyroids, lymph follicles, and epithelial tissues including carcinomas demonstrated lower SOS. SAM clearly discriminated structure of thyroid components corresponding to low magnification of light microscopy. Thyroid tumors were classified into three groups by average SOS: the fast group consisted of follicular adenomas/carcinomas and malignant lymphomas; the slow group contained poorly differentiated/undifferentiated carcinomas; and the intermediate group comprised papillary/medullary carcinomas.

The authors concluded that SAM imaging has the following benefits: precise images were acquired in a few minutes without special staining; structural irregularity and desmoplastic reactions, which indicated malignancy, were detected; images reflected tissue elasticity, which was statistically comparable among lesions by SOS; and tumor classification was predictable by SOS because more poorly differentiated carcinomas had a tendency to show lower SOS. The study was published on February 11, 2014, in the journal Pathology and Laboratory Medicine International.

Related Links:

Hamamatsu University School of Medicine 
Honda Electronics Co, Ltd 



New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.